Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001628280-16-020734
Filing Date
2016-11-03
Accepted
2016-11-03 16:08:01
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 admsforms-3november2016.htm S-3 255414
2 EXHIBIT 5.1 admsnovember2016ex51.htm EX-5.1 14003
3 EXHIBIT 23.1 admsnovember2016ex231.htm EX-23.1 2400
4 cooleyl.jpg GRAPHIC 10498
5 doc138312682v4adamasf_image1.jpg GRAPHIC 11911
  Complete submission text file 0001628280-16-020734.txt   298613
Mailing Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

EIN.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-214409 | Film No.: 161971636
SIC: 2834 Pharmaceutical Preparations